CYP2E1 and hemolytic-uremic syndrome: Although no prior reports directly link this combination to HUS, chlorzoxazone is a well-established in vivo probe for cytochrome P450 2E1 (CYP2E1) activity, and its metabolic activation has been associated with hepatic injury [32].